Data as of Dec 26
| +0.37 / +6.81%|
The 2 analysts offering 12-month price forecasts for Alimera Sciences Inc have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 10.00. The median estimate represents a +89.66% increase from the last price of 5.80.
The current consensus among 3 polled investment analysts is to Buy stock in Alimera Sciences Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.